Prospective Evaluation of Testosterone Fluctuations During a Transition from Degarelix to Leuprolide - Jack Zuckerman

Prospective Evaluation of Testosterone Fluctuations During a Transition of Therapy from Degarelix to Leuprolide in Patients on Androgen Deprivation Therapy

Jack Zuckerman, MD
Eastern Virginia Medical School
Norfolk, Virginia

SEE RELATED CONTENT:

Prospective evaluation of testosterone fluctuations during a transition of therapy from degarelix to leuprolide in patients on androgen deprivation therapy - Abstract

The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer - Abstract

BIOGRAPHY

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed his internship in General Surgery at the Naval Medical Center in San Diego and then went on to finish his Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He is currently a fellow in genitourinary reconstruction at Eastern Virginia.  His research interests are primarily male reconstruction, including ongoing prospective randomized controlled trials.  While his focus is urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology. 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe